Laboratory Testing for Vertigo Evaluation
Routine blood work is generally not indicated for the evaluation of vertigo, as the diagnosis relies primarily on clinical history, bedside examination, and targeted imaging when appropriate 1.
Clinical Context Over Laboratory Testing
The evidence strongly emphasizes that vertigo evaluation is fundamentally a clinical diagnosis based on:
- Timing and triggers of symptoms (brief episodic vs. acute persistent vs. chronic)
- Bedside physical examination including Dix-Hallpike testing, HINTS examination, and neurologic assessment
- Associated symptoms (hearing loss, tinnitus, neurologic deficits)
The 2024 ACR Appropriateness Criteria for dizziness and ataxia 1 make no recommendations for routine laboratory testing in their comprehensive imaging guidelines, focusing instead on clinical examination and selective imaging.
When Laboratory Tests May Be Considered
While not standard or guideline-recommended, specific laboratory tests may have limited utility in select scenarios:
Metabolic Screening (Limited Evidence)
Research suggests metabolic disorders may contribute to vestibular dysfunction 2:
- Lipid panel (LDL cholesterol)
- Thyroid function tests (TSH, T3, T4)
- Fasting glucose
Important caveat: This comes from a single 2012 observational study showing higher prevalence of metabolic abnormalities in vertigo patients, but this does not establish causation or treatment benefit. The clinical utility for morbidity/mortality outcomes remains unproven.
Orthostatic Function Testing
Bedside orthostatic vital signs (not laboratory tests) can help differentiate presyncope from true vertigo 3.
The Diagnostic Priority Algorithm
For typical BPPV (brief episodes triggered by head movement):
- Dix-Hallpike testing is diagnostic
- No imaging or laboratory testing needed 1
- Treat with Epley maneuver 4
For acute vestibular syndrome (persistent vertigo with nystagmus):
- HINTS examination by trained clinicians (not laboratory tests)
- MRI brain if central features present 1
- Laboratory tests do not contribute to stroke vs. vestibular neuritis differentiation
For recurrent episodic vertigo with hearing loss:
- Audiometry (not blood work) is the key test 3
- Consider Menière's disease
Cost-Effectiveness Evidence
A 1999 cost-effectiveness analysis 5 found that blood tests had the lowest cost-effectiveness among all diagnostic modalities for vertigo, while audiologic testing, posturography, and electronystagmography were most cost-effective.
Common Pitfalls to Avoid
- Do not order routine metabolic panels expecting to find a treatable cause of vertigo—the evidence doesn't support this practice
- Do not substitute laboratory testing for proper bedside examination—the Dix-Hallpike test and HINTS examination are far more diagnostically valuable
- Do not order CT head for isolated vertigo with normal neurologic exam—yield is <1% 1
- Be aware that patients may have vestibular dysfunction without classic vertigo symptoms, particularly older adults with "vestibular agnosia" 6
Bottom Line
Laboratory testing plays essentially no role in the standard evaluation of vertigo. The diagnosis depends on structured history (timing/triggers), targeted bedside examination (Dix-Hallpike, HINTS), audiometry when indicated, and selective MRI imaging for concerning features. If you're ordering blood work for vertigo, you're likely missing the actual diagnosis that can be made clinically.